SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem - Quaterly Results

25 Apr 2022 Evaluate
The topline advanced to Rs. 4987.95 millions, up 92.92% for the March 2022 quarter as against Rs. 2585.45 millions during the year-ago period.The company almost doubled its revenue to Rs. 990.88 millions  from Rs. 327.64 millions in the quarter ended March 2022.The company reported a good operating profit of 1770.77 millions compared to 802.63 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 4987.95 2585.45 92.92 15509.41 8286.00 87.18 15509.41 8286.00 87.18
Other Income 19.71 -0.25 -7984.00 41.11 21.89 87.80 41.11 21.89 87.80
PBIDT 1770.77 802.63 120.62 5135.97 2635.17 94.90 5135.97 2635.17 94.90
Interest 118.15 41.61 183.95 442.70 291.14 52.06 442.70 291.14 52.06
PBDT 1652.62 761.02 117.16 4693.27 2344.03 100.22 4693.27 2344.03 100.22
Depreciation 210.64 211.80 -0.55 859.06 735.45 16.81 859.06 735.45 16.81
PBT 1441.98 549.22 162.55 3834.21 1608.58 138.36 3834.21 1608.58 138.36
TAX 451.10 221.58 103.58 1306.36 600.19 117.66 1306.36 600.19 117.66
Deferred Tax 193.11 125.94 53.33 609.63 318.51 91.40 609.63 318.51 91.40
PAT 990.88 327.64 202.43 2527.85 1008.39 150.68 2527.85 1008.39 150.68
Equity 415.50 415.53 -0.01 415.50 415.53 -0.01 415.50 415.53 -0.01
PBIDTM(%) 35.50 31.04 14.36 33.12 31.80 4.13 33.12 31.80 4.13

Epigral Share Price

1101.85 38.20 (3.59%)
12-Jun-2026 11:17 View Price Chart
Peers
Company Name CMP
SRF 2702.50
BASF India 3303.60
Tata Chemicals 746.55
Pidilite Inds. 1546.30
Deepak Nitrite 1664.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: